Clinical Trials Browser

Phase 1 × envafolimab × 1 year × Clear all

NCT07260305 2025-12-03

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

Phase 1 Recruiting

Other solid neoplasm

Advanced or Metastatic Solid Tumors